ArticleBMC musculoskeletal disorders2026
Quantitative measurements for acetabular cartilage delamination on MRI.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeTo introduce the delamination width and delamination length for the quantitative description of the delamination between cartilage on MRI, and to determine the diagnostic value for acetabular cartilage delamination (ACD).
methodsData between January 2018 to December 2020 was reviewed. Patients diagnosed femoroacetabular impingement syndrome (FAIS) and underwent hip arthroscopy were included. Exclusion criteria were prior hip surgery and concomitant hip conditions. The delamination width and delamination length were measured at the coronal slice on magnetic resonance imaging (MRI) where the low-signal area on the fat-saturated proton density (FSPD) sequence was most apparent between the cartilage. The delamination width was measured along the direction of the radial line originating from the center of the femoral head. The delamination length was measured as the curve across the endpoints of delamination. The receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic value of these measurements.
resultsA total of 176 patients were included, with 69 (39.2%) patients diagnosed with ACD under arthroscopy. Patients with ACD demonstrated significant larger delamination width and delamination length compared to patients without ACD (all with P < 0.001). The area under curve (AUC) for delamination width and length predicting ACD was 0.8677 (95% CI: 0.8113 to 0.9240) and 0.8113 (95% CI: 0.7528 to 0.8698), respectively. The cut off value of delamination width was 0.95 mm, with the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) to be 89.9%, 74.8%, 70.0%, and 91.9%, respectively. The cut off value of delamination length was 2.80 mm, with the sensitivity, specificity, PPV, and NPV to be 43.0%, 94.2%, 90.2%, and 48.4%, respectively. Male sex and BMI were positively associated with delamination width and delamination length (all with P < 0.05).
conclusionThe delamination width and delamination length demonstrated good diagnostic value for ACD. Male sex and BMI were positively associated with these measurements. ACD may occur when the delamination width exceeds 0.95 mm and delamination length exceeds 2.80 mm in patients with FAIS. LEVEL OF EVIDENCE: Level III. Cohort study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.